2m 2m 2m 2m 2m 2m 2m
Regeneron Pharma (REGN)
NASDAQ
$664.00+$0.91 (+0.14%)
Price as of Jul 13, 2026 7:59 PM EDT- $68.5BMarket Cap
- 16.85%1-Year Change
- BiotechnologyIndustry
Regeneron Pharma (REGN)
$664.00+$0.91 (+0.14%)
REGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $663.09 | ||
Change | -$1.43 (-0.22%) | ||
Open | $661.63 | ||
High | $665.60 | ||
Low | $655.11 | ||
Previous Close | $664.52 | ||
Volume | 606,304 | ||
30-Day Average Volume | 1,021,330 | ||
1-Week Change | 2.04% | ||
1-Month Change | 8.32% | ||
1-Year Change | 16.85% | ||
3-Year Change | -7.27% | ||
5-Year Change | 15.87% | ||
Fundamentals | |||
Shares Outstanding | 103.0M | ||
Total Assets | $40.9B | ||
Market Cap | $68.5B | ||
Enterprise Value | $67.5B | ||
Period: QTR TTM FY | |||
Revenue | $1.5B | ||
Net Income | $727.2M | ||
Free Cash Flow | $848.3M | ||
EBIT | $831.2M | ||
EBITDA | $954.4M | ||
Net Working Capital | $13.1B | ||
EPS | $6.75 | ||
Enterprise Value/EBITDA | 71 | ||
Enterprise Value/Revenue | 44 | ||
P/B | 2 | ||
P/E | 98 | ||
PEG | -7 | ||
Price/Free Cash Flow | 81 | ||
Price/Operating Cash Flow | 63 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 0.57% | ||
Trailing Annual Dividend Yield | 0.55% | ||
Ex-Dividend Date | 05/20/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield